Dr. Brandon Crawford & Ryan Cedermark
The Research and Clinical Applications Behind Vagus Nerve Stimulation Through Laser and Electrical Therapy
The Research and Clinical Applications Behind Vagus Nerve Stimulation Through Laser and Electrical Therapy:
The presentation will include research behind vagus nerve stimulation and why it is important in brain injury, as well as clinical applications of vagus nerve stimulation through laser and electrical therapy.
About Dr. Brandon Crawford:
Dr. Brandon Crawford, DC FIBFN-CND is a fellow of the International Board of Functional Neurology with a specialty in Childhood Neurodevelopmental Disorders. He founded and leads care at the Austin Center for Developing Minds in Cedar Park, TX. Brandon is also the founder and CEO of NeuroSolution, who’s focus is selling laser therapy devices and educating doctors, therapists and lay people on various topics in healthcare. Dr. Crawford is also a managing partner of Legendary DC Consulting where he helps other practitioners achieve more optimal results by utilizing developmental functional neurology within their practice. Brandon is a managing partner for the NeuroSolution Center of Dubai and a similar clinic in the UK. Dr. Crawford serves on the medical advisory board for SNA Technologies and BrainTap. Dr. Crawford enjoys educating practitioners and has done this in various ways; most recently he has been a part of the Childhood Neurodevelopmental Disorders Courses led by Dr. Robert Melillo and is now involved in launching the NeuroSolution conferences across the nation. Dr. Brandon Crawford is dedicated to spreading the developmental functional neuroscience profession in order to achieve a larger impact on humanity. Currently Brandon’s main focus is on severe pediatric brain injuries and neurodevelopmental disorders. He is also an expert in laser and light therapy, specifically how to apply these modalities to the brain and nervous system. Brandon continues to develop new treatment strategies for various conditions to achieve a deeper level of healing for people all over the globe.
About Ryan Cedermark:
Paul G. Harch, M.D. is an emergency medicine and hyperbaric medicine clinician who is Clinical Professor of Medicine, Section of Emergency Medicine, at LSU School of Medicine, New Orleans, and former director of the University Medical Center Hyperbaric Medicine Department and LSU Hyperbaric Medicine Fellowship. Dr. Harch initiated and maintains a private practice that has resulted in the largest case experience in neurological hyperbaric medicine in the world. In this practice he adapted the concepts of conventional hyperbaric oxygen therapy to wounds in the central nervous system that spawned the subsequent academic and research practice. Beginning with brain injured divers and boxers in 1989, he applied his protocol to the first HBOT-treated cerebral palsy (1992) and autistic children (1996-2000) in this country and multiple other cerebral disorders, including most recently the first PET documented Alzheimer’s case (1/2019) and a subacute drowned child (Medical Gas Research 3/2017). This drowning case was the first demonstration of global regrowth of brain tissue in humans. He has now treated the largest series of drowned children in the world, over 100 children. In addition, He has successfully treated U.S. servicemen with TBI and PTSD, publishing the first case in 2009, a case series in 2012, a case-controlled series in 2019, and in March, 2020 a randomized controlled trial in civilians and veterans with mild traumatic brain injury. This human work was buttressed by application of the human protocol to animals in 2007 that stands as the first and only improvement of chronic brain injury in animals in the history of science. Dr. Harch’s work and perspective on hyperbaric oxygen therapy was published in his book, The Oxygen Revolution, where HBOT is explained as an epigenetic therapy with expected revolutionary effects on medicine and neurology. In March, 2020 he proposed the application of HBOT to COVID-19 pneumonia based on the successful use of hyperbaric treatment for dying Spanish Flu patients in 1918 and has now successfully treated patients with COVID-19 Long-Haulers Syndrome.